Ignite Creation Date:
2025-12-25 @ 12:07 AM
Ignite Modification Date:
2026-03-01 @ 4:45 PM
Study NCT ID:
NCT02305758
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2014-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Untreated Metastatic Colorectal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | PARP inhibitor | View |
| None | veliparib | View |
| None | metastatic colorectal cancer | View |
| None | ABT-888 | View |
| None | first line | View |
| None | previously untreated | View |
| None | colorectal cancer | View |
| None | colon cancer | View |
| None | rectal cancer | View |
| None | FOLFIRI | View |
| None | fluorouracil | View |
| None | 5-FU | View |
| None | leucovorin | View |
| None | irinotecan | View |